Antibiotic resistance is a public health problem that worsens the more we prescribe standard
dose antibiotics for acne. Regardless of race, acne vulgaris is one of the most common
dermatologic conditions among pediatric populations. As such, we can make a large impact by
practicing good antibiotic stewardship while still addressing the impact of acne on
adolescents' self-esteem. Subantimicrobial doxycycline maintains its anti-inflammatory
effects while eliminating antimicrobial properties and associated risks of drug resistance.
Few studies, focused primarily on adults, have shown that subantimicrobial doxycycline is
efficacious in treating acne from a physician standpoint. We aim to investigate the patient
experience of acne treatment with subantimicrobial dose doxycycline in the pediatric
population.